Company intelligence / Profile preview
Daewoong Infion
Pasuruan, East Java, Indonesiadaewoonginfion.co.id ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Daewoong Infion operates Indonesia’s first biopharmaceutical factory producing biological products and biosimilars from drug substance to finished product. Its lead commercial product is erythropoietin alpha (“Epodion”), the first locally manufactured biological in Indonesia. The company has a modern GMP-certified facility and focuses on affordable biologics for local and export markets. It collaborates with academic institutions and offers CMO services.
- Therapeutic areas
- HematologyEndocrinologyDermatology
- Modalities
- Recombinant proteinBiologicBiosimilar
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Universitas IndonesiaDaewoong Pharmaceutical Co., Ltd.PT. Infion
Beyond the preview
Go deeper on Daewoong Infion.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Daewoong Infion.